Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-13 2:30 pm Unchanged | 13G | ONCOSEC MED INC PAR $0.000 ONCS | SZOP MULTISTRAT LP | 0 0% | 0 (Unchanged) | View |
2023-05-25 4:13 pm Purchase | 13G | ONCOSEC MED INC PAR $0.000 ONCS | INTRACOASTAL CAPITAL LLC | 313,158 4.99% | 313,158 (New Position) | View |
2023-05-19 2:57 pm Purchase | 13G | ONCOSEC MED INC PAR $0.000 ONCS | SZOP Multistrat Management LLC | 257,118 5.65% | 257,118 (New Position) | View |
2023-04-17 4:01 pm Purchase | 13G | ONCOSEC MED INC PAR $0.000 ONCS | Lind Global Fund II LP | 460,733 9.9% | 460,733 (New Position) | View |
2023-02-14 12:50 pm Unchanged | 13G | ONCOSEC MED INC PAR $0.000 ONCS | Avidity Partners Management LP | 0 0% | 0 (Unchanged) | View |
2022-02-11 8:34 pm Purchase | 13G | ONCOSEC MED INC PAR $0.000 ONCS | Avidity Partners Management LP | 2,945,000 7.5% | 993,000 (+50.87%) | View |
2021-02-23 07:22 am Sale | 13D | ONCOSEC MED INC ONCS | Alpha Holdings Inc. | 1,718,251 4.85% | -180,999 (-9.53%) | View |
2021-02-16 11:38 am Purchase | 13G | ONCOSEC MED INC PAR $0.000 ONCS | Avidity Partners Management LP | 1,952,000 5.5% | 262,000 (+15.50%) | View |
2021-02-12 08:00 am Sale | 13G | ONCOSEC MED INC PAR $0.000 ONCS | Altium Capital Management LP | 614,000 2.2% | -100,000 (-14.01%) | View |
2020-12-30 2:33 pm Purchase | 13G | ONCOSEC MED INC PAR $0.000 ONCS | Avidity Partners Management LP | 1,690,000 6% | 1,690,000 (New Position) | View |
2020-11-18 1:53 pm Purchase | 13D | ONCOSEC MED INC ONCS | Alpha Holdings Inc. | 1,899,250 6.76% | 288,251 (+17.89%) | View |
2020-02-18 5:24 pm Purchase | 13D | ONCOSEC MED INC ONCS | China Grand Pharmaceutical & Healthcare Holdings Ltd | 10,000,000 44.1% | 10,000,000 (New Position) | View |
2020-02-14 1:33 pm Purchase | 13G | ONCOSEC MED INC PAR $0.000 ONCS | Altium Capital Management LP | 714,000 4.99% | 714,000 (New Position) | View |
2020-01-14 4:04 pm Unchanged | 13D | ONCOSEC MED INC ONCS | Alpha Holdings Inc. | 1,610,999 15.06% | 0 (Unchanged) | View |
2019-10-31 4:20 pm Unchanged | 13D | ONCOSEC MED INC ONCS | Alpha Holdings Inc. | 1,610,999 15.15% | 0 (Unchanged) | View |
2019-10-22 09:37 am Sale | 13D | ONCOSEC MED INC ONCS | Alpha Holdings Inc. | 1,610,999 15.15% | -1 (-0.00%) | View |
2019-10-15 08:40 am Purchase | 13D | ONCOSEC MED INC ONCS | Alpha Holdings Inc. | 1,611,000 15.15% | 120,000 (+8.05%) | View |
2019-06-03 5:17 pm Purchase | 13G | ONCOSEC MED INC PAR $0.000 ONCS | ARMISTICE CAPITAL LLC | 550,158 4.99% | 550,158 (New Position) | View |
2019-05-30 5:10 pm Purchase | 13G | ONCOSEC MED INC ONCS | Altium Capital Management LP | 952,000 9.99% | 952,000 (New Position) | View |
2019-05-29 8:07 pm Sale | 13D | ONCOSEC MED INC ONCS | Alpha Holdings Inc. | 1,491,000 14.2% | -8,509,000 (-85.09%) | View |